Visioneering Technologies, Inc. (ASX:VTI)
Australia
· Delayed Price · Currency is AUD 0.0660
0.00 (0.00%)
Feb 12, 2025, 3:55 PM AEST
Visioneering Technologies Company Description
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific.
Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia.
The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
Visioneering Technologies, Inc.
| Country | United States |
| Founded | 2008 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Juan Aragon |
Contact Details
Address: 30 Mansell Court Alpharetta, Delaware 30076 United States | |
| Phone | 844 884 5367 |
| Website | vtivision.com |
Stock Details
| Ticker Symbol | VTI |
| Exchange | Australian Securities Exchange |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | AU000000VTI2 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Dr. Juan Carlos Aragon | Chief Executive Officer and Executive Director |
| Dr. Kuang-Mon Tuan FAAO, Ph.D. | Chief Medical Officer |
| Dr. Richard A. Griffin OD | Founder and Medical Adviser |
| Jeff Pruett | Chief Financial Officer |
| Layna L. Mendlinger | Global Head of Marketing |
| Leanne Ralph AAICD, ACIS, BBus | Company Secretary |